“…This has also been seen in other small bowel disorders such as protein-losing enteropathies, where fecal loss of lymphocytes and alterations in lymphocyte subpopulations have been documented (17,18). In accordance with the findings of others (19) who reported lymphocyte counts returning to normal on GFD, we have also seen a significant increase in lymphocyte counts in GFD-treated patients; this is probably due to a decrease in lymphocyte leakage through the healed mucosa (Table 1). However, mean lymphocyte counts in GFD treated CD patients do not reach the values of healthy controls; in fact, treated CD patients do not complete reverse the mucosal alterations as to a healthy person, and this has been reinforced by two studies reporting persistent duodenal intraepithelial lymphocytosis even in long-term strictly adherent patients (20,21).…”